29
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Pizotif en once daily in the prophylaxis of migraine: results of a multi-centre general practice study

&
Pages 280-285 | Received 25 Jun 1984, Published online: 11 Aug 2008

References

  • Behan P. O. Pizotifen in the treatment of severe recurrent headache. Single and divided dose therapy compared. Br. J. Clin. Pract. 1982; 36: 13–171. Behan P. O. Pizotifen in the treatment of severe recurrent headache. Single and divided dose therapy compared. Br. J. Clin. Pract. 1982; 36: 13–17
  • Carroll J. D., Maclay W. P. Pizotifen (BC105) in migraine prophylaxis. Curr. Med. Res. Opin. 1975; 3: 68–712. Carroll J. D., Maclay W. P. Pizotifen (BC105) in migraine prophylaxis. Curr. Med. Res. Opin. 1975; 3: 68–71
  • Foster J. B. Further experience with pizotifen in the treatment of migraine. Curr. Ther. Res. 1976; 19: 66–693. Foster J. B. Further experience with pizotifen in the treatment of migraine. Curr. Ther. Res. 1976; 19: 66–69
  • Heathfield K. W. G., Stone P., Crowder D. Pizotifen in the treatment of migraine. Practitioner 1977; 218: 428–4304. Heathfield K. W. G., Stone P., Crowder D. Pizotifen in the treatment of migraine. Practitioner 1977; 218: 428–430
  • Hughes R. C., Foster J. B. BC105 in the prophylaxis of migraine. Curr. Ther. Res. 1971; 13: 63–685. Hughes R. C., Foster J. B. BC105 in the prophylaxis of migraine. Curr. Ther. Res. 1971; 13: 63–68
  • Lawrence E. R., Hossain M., Littlestone W. Sanomigran for migraine prophylaxis; controlled multi-centre trial in general practice. Headache 1977; 17: 109–1126. Lawrence E. R., Hossain M., Littlestone W. Sanomigran for migraine prophylaxis; controlled multi-centre trial in general practice. Headache 1977; 17: 109–112
  • Maclay W. P., Crowder D., Spiro S., Turner P. Postmarketing surveillance: practical experience with ketotifen. Br. Med. J. 1984; 288: 911–9147. Maclay W. P., Crowder D., Spiro S., Turner P. Postmarketing surveillance: practical experience with ketotifen. Br. Med. J. 1984; 288: 911–914
  • Mazal S., Rachmilewitz E. A. The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients. J. Neurol. Neurosurg. Psychiatry 1980; 43: 1137–11408. Mazal S., Rachmilewitz E. A. The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients. J. Neurol. Neurosurg. Psychiatry 1980; 43: 1137–1140
  • Meier J., Schreier E. Human plasma levels of some anti-migraine drugs. Headache 1976; 16: 96–1049. Meier J., Schreier E. Human plasma levels of some anti-migraine drugs. Headache 1976; 16: 96–104
  • Peet K. M. S. Use of pizotifen in severe migraine: a long-term study. Curr. Med. Res. Opin. 1977; 5: 192–19910. Peet K. M. S. Use of pizotifen in severe migraine: a long-term study. Curr. Med. Res. Opin. 1977; 5: 192–199
  • Speight T. M., Avery G. S. Pizotifen (BC105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 1972; 3: 159–20311. Speight T. M., Avery G. S. Pizotifen (BC105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 1972; 3: 159–203
  • Waters W. E. Community studies of the prevalence of headache. Headache 1970; 9: 178–18612. Waters W. E. Community studies of the prevalence of headache. Headache 1970; 9: 178–186

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.